In fact, our in silico analysis of 1926 NSCLC patients indicates a significantly increased overall survival associated with high expression levels of ITF2 and low expression of DKK1. The same findings, without statistical significance, were observed from our “in house” cohorts, probably due to the sample size. This evidence concerns the gene DKK1 and non-small cell lung carcinoma.